{"id":54293,"date":"2025-11-07T17:20:24","date_gmt":"2025-11-07T16:20:24","guid":{"rendered":"https:\/\/arbrea-labs.com\/?p=54293"},"modified":"2025-11-07T17:54:16","modified_gmt":"2025-11-07T16:54:16","slug":"new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know","status":"publish","type":"post","link":"https:\/\/arbrea-labs.com\/ko\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/","title":{"rendered":"\uccb4\uc911 \uac10\ub7c9 \uc57d\ubb3c\uc5d0 \ub300\ud55c \uc0c8\ub85c\uc6b4 \ubbf8\uad6d \uac00\uaca9 \ucc45\uc815 \uacc4\uc57d: \uc678\uacfc\uc758\uac00 \uc54c\uc544\uc57c \ud560 \uc0ac\ud56d"},"content":{"rendered":"<p data-start=\"413\" data-end=\"735\">On <strong data-start=\"416\" data-end=\"436\">November 6, 2025<\/strong>, the Donald Trump-led U.S. administration announced a landmark deal with major pharmaceutical manufacturers Eli Lilly and Novo Nordisk to <strong data-start=\"575\" data-end=\"641\">significantly reduce the cost of GLP-1-based weight-loss drugs<\/strong> for many Americans. Key points of the deal include:<\/p>\n<ul data-start=\"736\" data-end=\"1955\">\n<li data-start=\"736\" data-end=\"999\">\n<p data-start=\"738\" data-end=\"999\">A reduction in the monthly price of injectable GLP-1 medications (for example drugs like Wegovy, Zepbound) to approximately <strong data-start=\"862\" data-end=\"877\">$350\/month<\/strong>, with plans to bring them down to around <strong data-start=\"919\" data-end=\"934\">$245\/month<\/strong> over the next two years.<\/p>\n<\/li>\n<li data-start=\"1000\" data-end=\"1221\">\n<p data-start=\"1002\" data-end=\"1221\">For Medicare beneficiaries, the deal specifies <strong data-start=\"1049\" data-end=\"1081\">co-pays as low as $50\/month<\/strong> in certain cases, with the government negotiating the warehousing price down to around $245\/month.<\/p>\n<\/li>\n<li data-start=\"1432\" data-end=\"1686\">\n<p data-start=\"1434\" data-end=\"1686\">The deal also anticipates newly-approved <strong data-start=\"1475\" data-end=\"1492\">oral versions<\/strong> of GLP-1\/weight-loss medications coming to market in the near future, with starter pricing potentially as low as <strong data-start=\"1606\" data-end=\"1621\">$149\/month<\/strong> for oral formulations.<\/p>\n<\/li>\n<li data-start=\"1687\" data-end=\"1955\">\n<p data-start=\"1689\" data-end=\"1955\">Separately, a recent report by Swiss Re estimates that widespread adoption of GLP-1s in the U.S. could reduce mortality by up to 6.4% by 2045, signalling that the stakes for clinical, aesthetic and health systems are large.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"1957\" data-end=\"2022\"><strong data-start=\"1957\" data-end=\"2020\">Why this matters immediately for you, as a plastic surgeon:<\/strong><\/p>\n<ul data-start=\"2023\" data-end=\"2536\">\n<li data-start=\"2023\" data-end=\"2183\">\n<p data-start=\"2025\" data-end=\"2183\">Lower drug prices \u2192 wider access \u2192 more patients on weight-loss therapies \u2192 more bodies that may need contouring, skin-tightening, or aesthetic refinements.<\/p>\n<\/li>\n<li data-start=\"2184\" data-end=\"2345\">\n<p data-start=\"2186\" data-end=\"2345\">The shift from weight-loss being purely medical to <a href=\"https:\/\/arbrea-labs.com\/ko\/ozempic-face-a-new-challenge-for-medical-aesthetic-professionals-that-arbrea-face-helps-with\/\">weight-loss being aesthetic<\/a>\/transformational means demand for services rises and timeline of care changes.<\/p>\n<\/li>\n<li data-start=\"2346\" data-end=\"2536\">\n<p data-start=\"2348\" data-end=\"2536\">Insurance\/coverage environments are shifting: what once was inaccessible to many is becoming possibly mainstream, altering patient expectations, workflows and the way you consult and plan.<\/p>\n<\/li>\n<\/ul>\n<h2 data-start=\"2543\" data-end=\"2602\">What This Means for Aesthetic &amp; Reconstructive Practices<\/h2>\n<p data-start=\"2604\" data-end=\"2659\">More patients who\u2019ve lost large amounts of weight As weight-loss medications become more accessible and perhaps more widely used, you\u2019re likely to encounter a growing segment of patients who:<\/p>\n<ul data-start=\"2804\" data-end=\"3141\">\n<li data-start=\"2804\" data-end=\"2913\">\n<p data-start=\"2806\" data-end=\"2913\">Achieved significant weight reduction (10-30%+ of body weight) through GLP-1 therapy, diet and lifestyle.<\/p>\n<\/li>\n<li data-start=\"2914\" data-end=\"3027\">\n<p data-start=\"2916\" data-end=\"3027\">Are now left with consequences of that change: redundant skin, altered fat distribution, changed proportions.<\/p>\n<\/li>\n<li data-start=\"3028\" data-end=\"3141\">\n<p data-start=\"3030\" data-end=\"3141\">Are seeking aesthetic outcomes not simply \u201cweight removal\u201d but shape-definition and refinement of the new body.<\/p>\n<\/li>\n<\/ul>\n<h3 data-start=\"3143\" data-end=\"3194\">Strategic timing and staging of interventions<\/h3>\n<p data-start=\"3195\" data-end=\"3283\">Because these patients are on a weight-loss journey (often ongoing), your role shifts:<\/p>\n<ul data-start=\"3284\" data-end=\"3763\">\n<li data-start=\"3284\" data-end=\"3437\">\n<p data-start=\"3286\" data-end=\"3437\">Early phase: patients may still be losing weight. So you may emphasise <strong data-start=\"3357\" data-end=\"3384\">non-invasive tightening<\/strong>, <strong data-start=\"3386\" data-end=\"3413\">skin-quality treatments<\/strong>, smaller refinements.<\/p>\n<\/li>\n<li data-start=\"3438\" data-end=\"3552\">\n<p data-start=\"3440\" data-end=\"3552\">Later phase: once weight stabilises, you move to definitive contouring, excisional lifts, combined procedures.<\/p>\n<\/li>\n<li data-start=\"3553\" data-end=\"3646\">\n<p data-start=\"3555\" data-end=\"3646\">Communicating this staging clearly becomes a differentiator in patient trust and outcome.<\/p>\n<\/li>\n<li data-start=\"3647\" data-end=\"3763\">\n<p data-start=\"3649\" data-end=\"3763\">Visual planning tools (3D\/AR) that can show potential outcomes <strong data-start=\"3712\" data-end=\"3734\">post-stabilisation<\/strong> will be increasingly valued.<\/p>\n<\/li>\n<\/ul>\n<h3 data-start=\"3765\" data-end=\"3821\">Changing patient expectations &amp; financial pathways<\/h3>\n<ul data-start=\"3822\" data-end=\"4513\">\n<li data-start=\"3822\" data-end=\"3951\">\n<p data-start=\"3824\" data-end=\"3951\">Patients will ask: \u201cI\u2019ve done the weight-loss drug; what comes next?\u201d You become the partner in finishing the transformation.<\/p>\n<\/li>\n<li data-start=\"3952\" data-end=\"4157\">\n<p data-start=\"3954\" data-end=\"4157\">Because drug access is improving, aesthetic practices may need to educate patients on the difference between <strong data-start=\"4063\" data-end=\"4086\">medical weight loss<\/strong> and <strong data-start=\"4091\" data-end=\"4115\">aesthetic refinement<\/strong>, and how your value lies in the latter.<\/p>\n<\/li>\n<li data-start=\"4158\" data-end=\"4360\">\n<p data-start=\"4160\" data-end=\"4360\">Financial models shift: It won\u2019t just be \u201ccome in when you\u2019ve lost weight\u201d\u2014you may offer <strong data-start=\"4249\" data-end=\"4261\">packages<\/strong> around non-invasive + later surgical phases, or combo consults with medical-weight-loss clinics.<\/p>\n<\/li>\n<li data-start=\"4361\" data-end=\"4513\">\n<p data-start=\"4363\" data-end=\"4513\">Awareness that policy is changing: more coverage, more drugs, and more media attention. Patients may expect faster timelines or lower cost thresholds.<\/p>\n<\/li>\n<\/ul>\n<h2>Coming Soon: Arbrea Body<\/h2>\n<p data-start=\"4573\" data-end=\"4848\">At Arbrea Labs, we\u2019ve been watching this shift closely. Because when the weight-loss drug market transforms, the aesthetics market follows. That\u2019s why we\u2019re personally excited to announce that we are <strong data-start=\"4773\" data-end=\"4792\">about to launch<\/strong> <strong data-start=\"4793\" data-end=\"4808\">Arbrea Body, <\/strong>designed to meet exactly this moment.<\/p>\n<p data-start=\"4850\" data-end=\"4881\">Here\u2019s what to look forward to:<\/p>\n<ul data-start=\"4883\" data-end=\"5623\">\n<li data-start=\"4883\" data-end=\"5075\">\n<p data-start=\"4885\" data-end=\"5075\"><strong data-start=\"4885\" data-end=\"4917\">Future-oriented simulations:<\/strong> Not just \u201cwhat you look like today\u201d but \u201cwhat you will look like after weight loss + treatment\u201d, ideal for patients coming off GLP-1s or lifestyle change.<\/p>\n<\/li>\n<li data-start=\"5076\" data-end=\"5261\">\n<p data-start=\"5078\" data-end=\"5261\"><strong data-start=\"5078\" data-end=\"5108\">Seamless staging workflow:<\/strong> From early non-invasive tightening to definitive contouring, Arbrea Body will allow you to visualise the path and help patients buy into the timeline.<\/p>\n<\/li>\n<li data-start=\"5262\" data-end=\"5453\">\n<p data-start=\"5264\" data-end=\"5453\"><strong data-start=\"5264\" data-end=\"5308\">Patient-ready visuals that create trust:<\/strong> When a patient sees their \u201cafter stabilisation\u201d look while still in their \u201cduring weight loss\u201d stage, they feel future-oriented and confident.<\/p>\n<\/li>\n<li data-start=\"5454\" data-end=\"5623\">\n<p data-start=\"5456\" data-end=\"5623\"><strong data-start=\"5456\" data-end=\"5476\">Speed + privacy:<\/strong> Like our previous solutions, Arbrea Body is built to fit into busy clinics, respect patient confidentiality, and facilitate consults that convert.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"5625\" data-end=\"5770\">This isn\u2019t just a launch, it\u2019s a signal. A signal that the aesthetic industry is catching up to the weight-loss revolution. And you\u2019ll be ahead.<\/p>\n<h2 data-start=\"5777\" data-end=\"5811\">Key Takeaways for Your Practice<\/h2>\n<ul data-start=\"5813\" data-end=\"6526\">\n<li data-start=\"5813\" data-end=\"5959\">\n<p data-start=\"5815\" data-end=\"5959\">The pricing and coverage landscape for weight-loss drugs in the U.S. is undergoing a <strong data-start=\"5900\" data-end=\"5915\">major shift, <\/strong>faster access, lower cost, more patients.<\/p>\n<\/li>\n<li data-start=\"5960\" data-end=\"6107\">\n<p data-start=\"5962\" data-end=\"6107\">As that shift happens, aesthetic practices need to anticipate increased <strong data-start=\"6034\" data-end=\"6104\">demand for contouring, skin-quality treatments and staged pathways<\/strong>.<\/p>\n<\/li>\n<li data-start=\"6108\" data-end=\"6400\">\n<p data-start=\"6110\" data-end=\"6171\">To serve this new patient segment effectively, you\u2019ll need:<\/p>\n<ul data-start=\"6174\" data-end=\"6400\">\n<li data-start=\"6174\" data-end=\"6226\">\n<p data-start=\"6176\" data-end=\"6226\">Consult workflows tailored to \u201cpost-drug\u201d bodies<\/p>\n<\/li>\n<li data-start=\"6229\" data-end=\"6278\">\n<p data-start=\"6231\" data-end=\"6278\">Visualisation tools that map change over time<\/p>\n<\/li>\n<li data-start=\"6281\" data-end=\"6400\">\n<p data-start=\"6283\" data-end=\"6400\">Financial\/marketing plans that speak to patients who did the weight-loss medical work and now want aesthetic finish<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"6401\" data-end=\"6526\">\n<p data-start=\"6403\" data-end=\"6526\">With Arbrea Body on the horizon, you\u2019re in position to <strong data-start=\"6458\" data-end=\"6466\">lead<\/strong> the new kind of consult: from transformation to refinement.<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"2538\" data-end=\"2541\" \/>\n<h2 data-start=\"4644\" data-end=\"4657\">Sitography<\/h2>\n<ol data-start=\"4659\" data-end=\"6116\">\n<li data-start=\"4659\" data-end=\"4914\">\n<p data-start=\"4662\" data-end=\"4914\"><em data-start=\"4662\" data-end=\"4681\">Associated Press.<\/em> \u201cTrump says deal will cut costs of popular weight-loss drugs for millions of Americans.\u201d 6 Nov 2025.<br data-start=\"4782\" data-end=\"4785\" \/>\u2192 <a class=\"decorated-link\" href=\"https:\/\/apnews.com\/article\/15b24e03d558aa6bbcf37e52ba2d354e?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"4790\" data-end=\"4912\">https:\/\/apnews.com\/article\/15b24e03d558aa6bbcf37e52ba2d354e<\/a><\/p>\n<\/li>\n<li data-start=\"4915\" data-end=\"5162\">\n<p data-start=\"4918\" data-end=\"5162\"><em data-start=\"4918\" data-end=\"4934\">TIME Magazine.<\/em> \u201cWhite House deal lowers prices for weight-loss drugs.\u201d 7 Nov 2025.<br data-start=\"5002\" data-end=\"5005\" \/>\u2192 <a class=\"decorated-link\" href=\"https:\/\/time.com\/7331880\/white-house-deal-lowers-prices-weight-loss-drugs?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"5010\" data-end=\"5160\">https:\/\/time.com\/7331880\/white-house-deal-lowers-prices-weight-loss-drugs<\/a><\/p>\n<\/li>\n<li data-start=\"5163\" data-end=\"5429\">\n<p data-start=\"5166\" data-end=\"5429\"><em data-start=\"5166\" data-end=\"5181\">Investopedia.<\/em> \u201cTrump Negotiates Discounts for Weight-Loss Drugs.\u201d Nov 2025.<br data-start=\"5243\" data-end=\"5246\" \/>\u2192 <a class=\"decorated-link\" href=\"https:\/\/www.investopedia.com\/trump-negotiates-discounts-for-weight-loss-drugs-11845161?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"5251\" data-end=\"5427\">https:\/\/www.investopedia.com\/trump-negotiates-discounts-for-weight-loss-drugs-11845161<\/a><\/p>\n<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>On November 6, 2025, the Donald Trump-led U.S. administration announced a landmark deal with major pharmaceutical manufacturers Eli Lilly and Novo Nordisk to significantly reduce&#8230;<\/p>","protected":false},"author":3,"featured_media":54297,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,307],"tags":[],"class_list":["post-54293","post","type-post","status-publish","format-standard","has-post-thumbnail","category-arbrea-blog","category-innovation-and-future"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons<\/title>\n<meta name=\"description\" content=\"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/arbrea-labs.com\/ko\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons\" \/>\n<meta property=\"og:description\" content=\"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/arbrea-labs.com\/ko\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/\" \/>\n<meta property=\"og:site_name\" content=\"Arbrea Labs\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arbrealabs\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T16:20:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T16:54:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Selene Cabibbo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Selene Cabibbo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\ubd84\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/\"},\"author\":{\"name\":\"Selene Cabibbo\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#\\\/schema\\\/person\\\/016c4a63167f71667e28da2b91c9e25d\"},\"headline\":\"New U.S. Pricing Deal on Weight-Loss Drugs: What Surgeons Should Know\",\"datePublished\":\"2025-11-07T16:20:24+00:00\",\"dateModified\":\"2025-11-07T16:54:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/\"},\"wordCount\":878,\"publisher\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/pexels-haberdoedas-32532049-scaled.jpg\",\"articleSection\":[\"Arbrea Blog\",\"Innovation and Future\"],\"inLanguage\":\"ko-KR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/\",\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/\",\"name\":\"Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/pexels-haberdoedas-32532049-scaled.jpg\",\"datePublished\":\"2025-11-07T16:20:24+00:00\",\"dateModified\":\"2025-11-07T16:54:16+00:00\",\"description\":\"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#breadcrumb\"},\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#primaryimage\",\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/pexels-haberdoedas-32532049-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/pexels-haberdoedas-32532049-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"ozempic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arbrea-labs.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New U.S. Pricing Deal on Weight-Loss Drugs: What Surgeons Should Know\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#website\",\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/\",\"name\":\"Arbrea Labs\",\"description\":\"Augmented Reality &amp; 3D Solutions for Aesthetics\",\"publisher\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#organization\"},\"alternateName\":\"Arbrea\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/arbrea-labs.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#organization\",\"name\":\"Arbrea Labs\",\"alternateName\":\"Arbrea\",\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo_arbrea_LABS-01-1-e1641392734450.png\",\"contentUrl\":\"https:\\\/\\\/arbrea-labs.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo_arbrea_LABS-01-1-e1641392734450.png\",\"width\":2000,\"height\":750,\"caption\":\"Arbrea Labs\"},\"image\":{\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arbrealabs\",\"https:\\\/\\\/www.instagram.com\\\/arbrealabs\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/arbrea-labs-ag\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCbHN9gofXJv8rMAHcAguTcg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arbrea-labs.com\\\/#\\\/schema\\\/person\\\/016c4a63167f71667e28da2b91c9e25d\",\"name\":\"Selene Cabibbo\",\"description\":\"Selene Cabibbo is the Marketing Manager at Arbrea Labs, specializing in driving growth through innovative marketing strategies. With a strong focus on promoting AR and 3D simulation technologies for plastic surgery, she is dedicated to elevating the brand's presence and connecting with audiences worldwide.\",\"sameAs\":[\"http:\\\/\\\/arbrea-labs.com\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/selene-cabibbo\\\/\"],\"url\":\"https:\\\/\\\/arbrea-labs.com\\\/ko\\\/author\\\/da343753cff2c8bb7b8c58406ccfc0d6\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons","description":"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/arbrea-labs.com\/ko\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/","og_locale":"ko_KR","og_type":"article","og_title":"Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons","og_description":"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.","og_url":"https:\/\/arbrea-labs.com\/ko\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/","og_site_name":"Arbrea Labs","article_publisher":"https:\/\/www.facebook.com\/arbrealabs","article_published_time":"2025-11-07T16:20:24+00:00","article_modified_time":"2025-11-07T16:54:16+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg","type":"image\/jpeg"}],"author":"Selene Cabibbo","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Selene Cabibbo","Est. reading time":"4\ubd84"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#article","isPartOf":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/"},"author":{"name":"Selene Cabibbo","@id":"https:\/\/arbrea-labs.com\/#\/schema\/person\/016c4a63167f71667e28da2b91c9e25d"},"headline":"New U.S. Pricing Deal on Weight-Loss Drugs: What Surgeons Should Know","datePublished":"2025-11-07T16:20:24+00:00","dateModified":"2025-11-07T16:54:16+00:00","mainEntityOfPage":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/"},"wordCount":878,"publisher":{"@id":"https:\/\/arbrea-labs.com\/#organization"},"image":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#primaryimage"},"thumbnailUrl":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg","articleSection":["Arbrea Blog","Innovation and Future"],"inLanguage":"ko-KR"},{"@type":"WebPage","@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/","url":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/","name":"Trump\u2019s GLP-1 Deal: What It Means for Plastic Surgeons","isPartOf":{"@id":"https:\/\/arbrea-labs.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#primaryimage"},"image":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#primaryimage"},"thumbnailUrl":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg","datePublished":"2025-11-07T16:20:24+00:00","dateModified":"2025-11-07T16:54:16+00:00","description":"Learn how the new agreement affects GLP-1 drug prices, making weight-loss options more accessible for many Americans.","breadcrumb":{"@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#breadcrumb"},"inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/"]}]},{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#primaryimage","url":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg","contentUrl":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2025\/11\/pexels-haberdoedas-32532049-scaled.jpg","width":2560,"height":1920,"caption":"ozempic"},{"@type":"BreadcrumbList","@id":"https:\/\/arbrea-labs.com\/new-u-s-pricing-deal-on-weight-loss-drugs-what-surgeons-should-know\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/arbrea-labs.com\/"},{"@type":"ListItem","position":2,"name":"New U.S. Pricing Deal on Weight-Loss Drugs: What Surgeons Should Know"}]},{"@type":"WebSite","@id":"https:\/\/arbrea-labs.com\/#website","url":"https:\/\/arbrea-labs.com\/","name":"\uc544\ube0c\ub808\uc544 \ub7a9\uc2a4","description":"\ubbf8\uc6a9\uc744 \uc704\ud55c \uc99d\uac15 \ud604\uc2e4 \ubc0f 3D \uc194\ub8e8\uc158","publisher":{"@id":"https:\/\/arbrea-labs.com\/#organization"},"alternateName":"Arbrea","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arbrea-labs.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ko-KR"},{"@type":"Organization","@id":"https:\/\/arbrea-labs.com\/#organization","name":"\uc544\ube0c\ub808\uc544 \ub7a9\uc2a4","alternateName":"Arbrea","url":"https:\/\/arbrea-labs.com\/","logo":{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/arbrea-labs.com\/#\/schema\/logo\/image\/","url":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2022\/01\/logo_arbrea_LABS-01-1-e1641392734450.png","contentUrl":"https:\/\/arbrea-labs.com\/wp-content\/uploads\/2022\/01\/logo_arbrea_LABS-01-1-e1641392734450.png","width":2000,"height":750,"caption":"Arbrea Labs"},"image":{"@id":"https:\/\/arbrea-labs.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arbrealabs","https:\/\/www.instagram.com\/arbrealabs\/","https:\/\/www.linkedin.com\/company\/arbrea-labs-ag\/","https:\/\/www.youtube.com\/channel\/UCbHN9gofXJv8rMAHcAguTcg"]},{"@type":"Person","@id":"https:\/\/arbrea-labs.com\/#\/schema\/person\/016c4a63167f71667e28da2b91c9e25d","name":"\uc140\ub808\ub124 \uce74\ube44\ubcf4","description":"\uc140\ub808\ub124 \uce74\ube44\ubcf4(Selene Cabibbo)\ub294 \uc544\ube0c\ub808\uc544 \ub77c\ubcf4\ub7ec\ud1a0\ub9ac\uc2a4(Arbrea Labs)\uc758 \ub9c8\ucf00\ud305 \ub9e4\ub2c8\uc800\ub85c, \ud601\uc2e0\uc801\uc778 \ub9c8\ucf00\ud305 \uc804\ub7b5\uc744 \ud1b5\ud574 \uc131\uc7a5\uc744 \uc774\ub044\ub294 \uc804\ubb38\uac00\uc785\ub2c8\ub2e4. \uc131\ud615\uc678\uacfc\ub97c \uc704\ud55c AR \ubc0f 3D \uc2dc\ubbac\ub808\uc774\uc158 \uae30\uc220 \ud64d\ubcf4\uc5d0 \uc8fc\ub825\ud558\uba70, \ube0c\ub79c\ub4dc\uc758 \uc785\uc9c0\ub97c \ub192\uc774\uace0 \uc804 \uc138\uacc4 \uccad\uc911\uacfc \uc18c\ud1b5\ud558\uae30 \uc704\ud574 \ud798\uc4f0\uace0 \uc788\uc2b5\ub2c8\ub2e4.","sameAs":["http:\/\/arbrea-labs.com","https:\/\/www.linkedin.com\/in\/selene-cabibbo\/"],"url":"https:\/\/arbrea-labs.com\/ko\/author\/da343753cff2c8bb7b8c58406ccfc0d6\/"}]}},"_links":{"self":[{"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/posts\/54293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/comments?post=54293"}],"version-history":[{"count":0,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/posts\/54293\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/media\/54297"}],"wp:attachment":[{"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/media?parent=54293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/categories?post=54293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arbrea-labs.com\/ko\/wp-json\/wp\/v2\/tags?post=54293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}